3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
38
Carcinoma, Non-Small-Cell Lung
23
Lung Neoplasms
10
Neoplasm Metastasis
7
Hodgkin Disease
6
Recurrence
4
Neoplasms
4
Uterine Cervical Neoplasms
3
Sarcoma
2
Rhabdomyosarcoma
2
Mesothelioma
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Carcinoma
2
Breast Neoplasms, Male
2
Brain Neoplasms
2
Triple Negative Breast Neoplasms
1
Rhabdomyosarcoma, Embryonal
1
Rhabdomyosarcoma, Alveolar
1
Pleural Effusion, Malignant
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Non - Small Cell Lung Cancer NSCLC
1
Neuroendocrine Tumors
1
Neuralgia
1
Metatropic dwarfism
1
Melanoma
1
Lymphoma, T-Cell, Peripheral
1
Locally Advanced Non-Small Cell Lung Cancer
1
Lethal Congenital Contracture Syndrome 2
1
Glioma
1
Interventions
Magnetic Resonance Spectroscopy
2
Everolimus
2
Erlotinib Hydrochloride
2
ribociclib
1
palbociclib
1
olaparib
1
etoposide phosphate
1
erdafitinib
1
X-Rays
1
Sunitinib
1
Specimen Handling
1
Radiotherapy
1
Phantoms, Imaging
1
Nuclear Medicine Department, Hospital
1
N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine
1
Microarray Analysis
1
Lapatinib
1
Irinotecan
1
Immunologic Techniques
1
Immunohistochemistry
1
Immunoglobulin G
1
Ifosfamide
1
Fluorodeoxyglucose F18
1
Etoposide
1
Donepezil
1
Disulfides
1
Dasatinib
1
Cyproheptadine
1
Carboplatin
1
Blotting, Western
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Familial ependymoma
×
Vinorelbine
×
Clear all
No trials found.